HSCs and Myelopoiesis

 Friday, May 6, 2022     2:00 PM – 4:00 PM ET     Room B117–119

HSCs and Myelopoiesis

Chairs

• Anna Beaudin, Sch. of Med., Univ. of Utah
• Jeffrey Bednarski, Washington Univ. Sch. of Med.

Speakers

• Stephanie Crowley, Washington Univ. Sch. of Med., Bclaf1 promotes hematopoietic stem cell repopulating capacity and self-renewal
• Momoko Yoshimoto, McGovern Med. School, Univ. of Texas Hlth. Sci. Ctr. at Houston, HSC-independent definitive lymphopoiesis persists into adult life
• Jennifer E. Howard, Albany Med. College, IL-18R signaling impairs hematopoietic recovery after severe, shock-like infection
• Marion Lacroix, IRCM, The X-linked gene for the helicase DDX3X is required for lymphoid differentiation and MYC-driven lymphomagenesis
• Betsabel J. Chicana, Sch. of Natural Sci., Univ. of California Merced, Vhl deficiency in Dmp1-expressing cells affects myeloid development and erythropoiesis: possible effects on myeloerythroid metabolism
• Tiantian Liu, Washington Univ. Sch. of Med. in St. Louis, Ablation of cDC2 lineage specification by mutations within the δ−165 kb Zeb2 enhancer
• Jayashree Srinivasan, Univ. of Texas at Austin, Cellular and molecular mediators of thymic DC homeostasis and activation
• Diego A. Lopez, Univ. of Utah Sch. of Med., Maternal immune activation (MIA) impairs neonatal lung ILC2 establishment, function, and airway hyperresponsiveness